We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Launches Trial of Rheumatoid Arthritis Drug Otilimab for COVID-19
GSK Launches Trial of Rheumatoid Arthritis Drug Otilimab for COVID-19
GlaxoSmithKline (GSK) has launched a phase 2 trial in the UK of its investigational rheumatoid arthritis treatment otilimab for hospitalized COVID-19 patients.